<DOC>
	<DOCNO>NCT01675791</DOCNO>
	<brief_summary>The primary aim trial evaluate dose-response relationship ALK tree AIT administer daily order define dose-range would suitable at-home administration .</brief_summary>
	<brief_title>A Dose-response Evaluation ALK ( Sponsor ) Tree Allergy Immunotherapy Tablet</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>A history moderate severe birch pollen allergy Use symptomatic medication treatment birch pollen allergy Positive skin prick test birch extract Positive specific IgE Bet v 1 Overlapping perennial allergy History uncontrolled asthma within last 3 month FEV1 &lt; 70 % predict value adult FEV1 &lt; 80 % predict value adolescent Previous ongoing treatment immunotherapy</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>